Loading clinical trials...

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 2/3NCT02729116

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

This study evaluates oral antimicrobial agents for the treatment of non-bacteremic acute urinary tract infection caused by Extended Spectrum Beta Lactamase producing Escherichia coli or Klebsiella pne...

Lead sponsor: Khon Kaen University•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

TERMINATED

Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria

NCT03869593 · Escherichia Coli Infections, Staphylococcus Aureus

COMPLETEDNA

Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli

NCT02541695 · Diarrhea, Gastroenteritis, and more

COMPLETED

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

NCT00363220 · Infection, E Coli Infections, and more

COMPLETED

Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4

NCT01406288 · Hemolytic-uremic Syndrome, Escherichia Coli Infections

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 8, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2/PHASE3

Enrollment30

Start dateJul 2016

Last updatedMar 8, 2023

Condition

Anti-Infective Agents, Urinary Escherichia Coli Infections Klebsiella Infections Kidney Transplantation Urinary Tract Infections

Locations shown

Khon Kaen University

Ban Khanaen, Khonkaen

Khon Kaen University

Ban Khanaen, Khonkaen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 8, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions